A Multi-Part, Randomized, Single-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous TRV130A in Healthy Adult Males.
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Oliceridine (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- 07 Feb 2018 Results of pooled data from six phase 1 and phase 2 trial assessing population pharmacokinetic/pharmacodynamic (PK/PD) model of the PK and PD of oliceridine, were published in the Journal of Clinical Pharmacology.
- 14 Oct 2013 Results published in the Journal of Clinical Pharmacology.
- 23 Aug 2012 Last checked against ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History